Genetics offers enormous promise for human health, and for enabling transformative change in our healthcare system. However, the practical barriers to integrating genetics into clinical care delivery are undeniable. Because genetics is inherently data-intensive, critical challenges relate to the data and digital infrastructure that span across research, care delivery, and payment.
At the Genetic Health Information Network Summit, 100 top leaders from across healthcare, genetics, and technology gather to discuss critical improvements to the systems connecting genetic information in healthcare. The group, which includes CEOs, CMOs, CMIOs, Department Chairs, Research Directors, Managing Directors, Professors, Policymakers, and Patient Advocates, comes together for a candid, solution-oriented discussion on how to collectively overcome the barriers to achieving precision medicine at scale.
If this meeting sounds of interest to you, the organizers would be pleased to provide a 20-minute briefing about the meeting, format, and participant base to help you determine whether it’s a good match for your interests and goals.
If you would like to learn more, please complete the form. A meeting organizer will contact you to arrange a briefing.
Topics of Focus
For a sample of the topics covered at the Summit, download this whitepaper, which details the five core issues that emerged from the inaugural event:
- Genetic testing laboratory quality and patient safety;
- Clinical validity, utility, and value assessment at scale;
- Genetic test identification for market tracking, evidence-gathering, billing, and payment;
- Provider education, communication, and support at the point-of-care; and
- Patient access and control of genetic data.
Complete the form to download the paper.
Past Organizers, Speakers & Authors
CARLOS BUSTAMANTE, PhD
Venture Partner
F-Prime Capital
PRISCILLA ALFARO, MD
Chief Medical Officer
Zelis
ESTEBAN LÓPEZ
Chief Medical Officer, Clinical Strategy Innovation
HCSC (BCBS of IL, MT, NM, OK & TX)
MARA ASPINALL
CEO
Health Catalysts Group
GILLIAN HOOKER, PhD, ScM, LCGC
VP, Clinical Development
Concert Genetics
SUZANNE BELINSON, PhD, MPH
VP, Commercial Markets
Tempus
ROBERT NUSSBAUM, MD
Chief Medical Officer
Invitae
DEE ANNA SMITH
CEO
Sarah Cannon
GEORGE CARDOZA
Senior Vice President, Chief Financial Officer
NeoGenomics
SEAN HOFHERR, PhD
Chief Scientific Officer
GeneDx, Inc.
JULIE M EGGINGTON, MS, PhD
Co-founder & CEO
Center for Genomic Interpretation
GERALD FELDMAN, MD, PhD
President
American College of Medical Genetics & Genomics
MARY FREIVOGEL, MS, CGC
President
National Society of Genetic Counselors
ERYNN GORDON, MS, LCGC
VP, Clinical Operations
Genome Medical
NIKOLETTA SIDIROPOULOS, MD
Medical Director, Genomic Medicine, Department of Pathology and Laboratory Medicine
University of Vermont Health Network
BAS VAN DER BAAN
Chief Clinical Officer
Agendia
HOWARD LEVY, MD, PhD
Associate Professor of Medicine
Johns Hopkins Medicine
KATE DONIGAN, PHD
Deputy Director, Personalized Medicine & Molecular Genetics (acting)
FDA
JIM JIRJIS, MD
Chief Health Information Officer
HCA Healthcare
LEE N. NEWCOMER, MD, MHA
SVP, Oncology and Genetics
UnitedHealthcare
BENJAMIN SOLOMON, MD, FACMG
Clinical Director, National Human Genome Research Institute (NHGRI)
NIH
ROBERT C. GREEN, MD, MPH
Director, Genomes2People
Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School
DAN RODEN, MD
Senior Vice President, Personalized Medicine
Vanderbilt University Medical Center
NICOLE BOICE
Founder & CEO
Global Genes
DAVID MCCALLIE, MD
SVP, Medical Informatics
Cerner
EDWARD ABRAHAMS, PhD
President
Personalized Medicine Coalition
TAHA KASS-HOUT, MD
Former 1st Chief Health Informatics Officer
U.S. Food and Drug Administration (FDA)
GIL ALTEROVITZ, PhD
Director, Biomedical Cybernetics Laboratory
Harvard Medical School
KRISTINE BORDENAVE, MD
Corporate Medical Director
Humana
JOSHUA DENNY, MD
Professor of Biomedical Informatics and Medicine
Vanderbilt University
HENRY GARLICH
Director, Healthcare Value Solutions & Enhanced Clinical Programs
Blue Shield of California
TRENT HAYWOOD, MD, JD
SVP & Chief Medical Officer
Blue Cross Blue Shield Association
STEPHANIE DEVANEY, PHD
Deputy Director, All of Us
NIH
LISA ALDERSON
Co-founder & CEO
Genome Medical
KATHRYN LANG, MD
Global Medical Strategy Head of Data Science
Pfizer
MATT MIGHT, PhD
Director, Hugh Kaul Personalized Medicine Institute
University of Alabama at Birmingham
LAURIE MCGRAW
SVP, Health Solutions
American Medical Association
VICTORIA PRATT, PhD
President
Association for Molecular Pathology
DAWN BARRY
Co-Founder and President
Luna DNA
ELI CASDIN
Chief Investment Officer
Casdin Capital
ELLEN MATLOFF, MS, CGC
President & CEO
My Gene Counsel
JULIE RAMAGE
National Accounts Director, Diagnostics
Pfizer
ALEX DE WINTER
Managing Director
GE Ventures
NICK NACLERIO, PhD
Founding Partner
Illumina Ventures
EMILY EDELMAN, MS, CGC
Associate Director of Clinical & Continuing Education
The Jackson Laboratory
JAMES O’LEARY
Chief Innovation Officer
Genetic Alliance
BRYCE OLSON
Global Marketing Director, Health and Life Sciences
Intel